BSE filing, BSE: 540718. Summary written from the filing by ALFA Finder's alert engine.
Aayush Art and Bullion Ltd: key numbers
- Share price
- ₹1,321.00
- Market cap
- ₹2,023 Cr
- Revenue (annual)
- ₹216.3 Cr
- Net profit (annual)
- ₹7.89 Cr
- P/E (TTM)
- 256.3×Sector 49.5×
- Promoter holding
- 24.63%
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aayush Art and Bullion Ltd
All →Aayush Art and Bullion Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the period ended September 30, 2026.
Aayush Art and Bullion Management Change
Independent Director Mr. Afsar Ismail Khan has resigned from the board of Aayush Art and Bullion Limited, effective October 5, 2026, citing personal reasons.
Aayush Art and Bullion Management Change
Aayush Art and Bullion Limited announced the resignation of director Piyush Parmar and the appointment of Bikash Rasily as an additional non-executive director.
Aayush Art and Bullion Annual General Meeting
Aayush Art and Bullion Limited held its 17th Annual General Meeting on September 10, 2026. Shareholders transacted ordinary and special business items during the meeting.
Aayush Art and Bullion Board Meeting Outcome
The company appointed Mr. Belim Rifaqathussain Mehboobbhai as the Chief Financial Officer (CFO), effective August 24, 2026.
Aayush Art and Bullion Management Change
Aayush Art and Bullion Limited appointed Mr. Anuj Maheswari as Company Secretary and Compliance Officer. Additionally, the company noted the resignation of CFO Ms. Bhagyashri Shyambihari Agrawal.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.